Local Ablative Therapy Combined With Pembrolizumab in Patients With Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Recursive Partitioning Analysis

被引：0
|
作者：
Lee, Hye In [1 ]
Choi, Eun Kyung [1 ]
Kim, Su Ssan [1 ]
Shin, Young Seob [1 ]
Park, Junhee [1 ]
Choi, Chang-Min [2 ,3 ]
Yoon, Shinkyo [2 ]
Kim, Hyeong Ryul [4 ]
Cho, Young Hyun [5 ]
Song, Si Yeol [1 ]
机构：
[1] Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
[2] Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
[3] Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
[4] Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
[5] Department of Neurosurgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of
来源：
International Journal of Radiation Oncology Biology Physics | / 120卷 / 03期
关键词：
Ablative therapy - Analysis models - Hazard ratio - Metastatic lesions - Methods and materials - Non small cell lung cancer - Overall survival - Progression free survival - Recursive partitioning analysis - Risk groups;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
25
引用
收藏
页码：698 / 707
相关论文
共 50 条
  • [21] Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 21 - 24
  • [22] Local therapy treatment conditions for oligometastatic non-small cell lung cancer
    Zhang, Suli
    Sun, Qian
    Cai, Feng
    Li, Hui
    Zhou, Yufu
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [23] The emerging role of local therapy in oligometastatic non-small cell lung cancer
    Isbell, James M.
    Li, Bob T.
    Gomez, Daniel R.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 163 (03): : 819 - 825
  • [24] Ablative therapy in oligometastatic non-small cell lung cancer-an editorial on recent evidence
    Niglas, Mark
    Cheung, Patrick
    JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 138 - 140
  • [25] Local Consolidative Therapy May Be Beneficial in Patients With Oligometastatic Non-Small Cell Lung Cancer
    Barton, Mary Kay
    CA-A CANCER JOURNAL FOR CLINICIANS, 2017, 67 (02) : 89 - 90
  • [26] Phase II Study of Pembrolizumab for Oligometastatic Non-Small Cell Lung Cancer (NSCLC) Following Completion of Locally Ablative Therapy (LAT)
    Bauml, J.
    Mick, R.
    Ciunci, C.
    Aggarwal, C.
    Davis, C.
    Evans, T.
    Deshpande, C.
    Miller, L.
    Patel, P.
    Alley, E.
    Knepley, C.
    Mutale, F.
    Cohen, R.
    Langer, C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S335 - S336
  • [27] Phase II Study of Pembrolizumab for Oligometastatic Non-Small Cell Lung Cancer (NSCLC) Following Completion of Locally Ablative Therapy (LAT)
    Bauml, J.
    Mick, R.
    Ciunci, C.
    Aggarwal, C.
    Evans, T.
    Miller, L.
    Muhammad, N.
    Alley, E.
    Knepley, C.
    Mutale, F.
    Cohen, R.
    Langer, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1794 - S1795
  • [28] Local consolidating Radiotherapy in Patients with oligometastatic Non-small cell Lung Cancer
    Fabian, Alexander
    Pyschny, Florian
    Krug, David
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (12) : 1113 - 1115
  • [29] Management of Synchronous Extrathoracic Oligometastatic Non-Small Cell Lung Cancer
    Jones, Gregory D.
    Lengel, Harry B.
    Hsu, Meier
    Tan, Kay See
    Caso, Raul
    Ghanie, Amanda
    Connolly, James G.
    Bains, Manjit S.
    Rusch, Valerie W.
    Huang, James
    Park, Bernard J.
    Gomez, Daniel R.
    Jones, David R.
    Rocco, Gaetano
    CANCERS, 2021, 13 (08)
  • [30] Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer
    Ricardi, Umberto
    Levra, Niccolo Giaj
    Badellino, Serena
    Alongi, Filippo
    JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2235 - 2237
12345